A search for a mutation in the tumour necrosis factor-alpha gene in narcolepsy

Psychiatry and Clinical Neurosciences

Volumn 53, Issue 3, 1999, Pages 421-423

  Kato, Tadafumi ^a   Honda, Makoto ^b   Kuwata, Shouji ^c   Juji, Takeo ^d   Fukuda, Masato ^a   Honda, Yutaka ^e   Kato, Nobumasa ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

^c TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Japanese Red Central Blood Center   (Japan)

^e NEUROPSYCHIATRIC RESEARCH INSTITUTE   (Japan)

Author keywords

Cytokines; Human leucocyte antigens; Molecular genetics; Narcolepsy; Sleep disorders; Tumour necrosis factor

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DR2 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; GENE CLUSTER; GENE MUTATION; GENE SEQUENCE; HUMAN; INTRON; MOLECULAR BIOLOGY; NARCOLEPSY; SINGLE STRAND CONFORMATION POLYMORPHISM;

DNA MUTATIONAL ANALYSIS; EXONS; HLA-DR2 ANTIGEN; HUMANS; INTRONS; MOLECULAR SEQUENCE DATA; NARCOLEPSY; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032855449     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1819.1999.00568.x     Document Type: Article

References (17)

1. Honda Y, Juji T. HLA in Narcolepsy, Springer-Verlag, Tokyo, 1988.
2. Honda Y, Doi Y, Juji T, Satake M, Narcolepsy and HLA. Positive DR2 as a prerequisite for the development of narcolepsy. Folia Psychiatr. Neurol. Jpn. 1984; 38: 360.
3. Juji T, Satake M, Honda Y et al. HLA antigens in Japanese patients with narcolepsy: All the patients were DR2 positive. Tissue Antigen 1984; 24: 316-319.
4. Mignot E, Kimura A, Lattermann A et al. Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy. Tissue Antigens 1997; 49: 329-341.
5. Rogers AE, Meehan J, Guilleminault C et al. HLA DR15 (DR2) and DQB1*0602 typing studies in 188 narcoleptic patients with cataplexy. Neurology 1997; 48: 1550-1556.
6. Krueger JM, Majde JA. Cytokines and sleep. Int. Arch. Allergy Immunol. 1995; 106: 97-100.
7. Fang J, Wang Y, Krueger JM. Mice lacking the TNF 55 kDa receptor fail to sleep more after TNF-α treatment. J. Neurosci. 1997; 17: 5949-5955.
8. Kanbayashi T, Nishino S, Tafti M et al. Thalidomide, a hypnotic with immune modulating properties, increases cataplexy in canine narcolepsy. Neuroreport 1996; 7: 1881-1886.
9. Vgontzas AN, Papanicolaou DA, Bixler EO et al. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J. Clin. Endocrinol. Metab. 1997; 82: 1313-1316.
10. Van Ostade X, Tavernier J, Fiers W. Structure-activity studies of human tumour necrosis factors. Protein Eng. 1994; 7: 5-22.
11. Rink L, Kirchner H. Recent progress in the tumor necrosis factor-alpha field. Int. Arch. Allergy Immunol. 1996; 111: 199-209.
12. Weinshenker BG, Wingerchuk DM, Liu Q et al. Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis. Neurology 1997; 49: 378-385.
13. Nedwin GE, Naylor SL, Sakaguchi AY et al. Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucl. Acids Res. 1985; 13: 6361-6373.
14. Orita M, Suzuki Y, Sekiya T et al. Rapid and sensitive detection of point mutation and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5: 874-879.
15. Diagnostic Classification Steering Committee. ICSD-International Classification of Sleep Disorders: Diagnostic and Coding Manual. Thorpy, MJ (Chairman). American Sleep Disorders Association, Rochester, 1990.
16. Kato T, Honda M, Kuwata S et al. A novel polymorphism in the promoter region of the tumor necrosis factor alpha gene: No association with narcolepsy. Am. J. Med. Genet. 1999; in press.
17. Ravnik-Glavac M, Glavac D, Dean M. Sensitivity of single-strand conformation polymorphism and heteroduplex method for mutation detection in the cystic fibrosis gene. Hum. Mol. Genet. 1994; 3: 801-807.